Home LiteratureArticle Details
PMID: 2189890 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.

The Journal of clinical investigation ·Vol. 85 ·No. 6 ·1990-06-00 ·Pages 1746-53

Bhakdi S, Muhly M, Korom S, Schmidt G

Abstract

This study reports on the potent cytocidal and interleukin-1 releasing properties of Escherichia coli hemolysin (ECH) on human monocytes. Nanomolar concentrations of purified ECH (250-2,000 ng/ml) caused rapid and irreversible depletion of cellular ATP to levels below 20% of controls within 60 min. Subcytocidal doses (10-200 ng/ml) of ECH induced rapid release within 60-120 min of large amounts of interleukin 1 beta (IL-1 beta) from cultured monocytes. IL-1 beta release occurred in the presence of actinomycin D and cycloheximide, and was thus probably due to processing and export of intracellular IL-1 beta precursor. Incubation of toxin-producing E. coli at ratios of only 0.3-3 colony-forming units per monocyte evoked approximately 50% depletion of total cellular ATP within 90 min. Toxin producers also stimulated synthesis and release of large amounts of interleukin 1, but not of tumor necrosis factor within the same time span. In contrast, non-toxin producers caused neither cell death nor rapid interleukin 1 release. Stimulation of rapid interleukin 1 release coupled with potent cytocidal effects on cells of monocytic origin may represent pathogenetically significant events incurred by bacterial strains that produce ECH and related cytolysins.

MeSH Terms
Adenosine Triphosphate/metabolism Cell Survival/drug effects Cells, Cultured Drug Synergism Escherichia coli/pathogenicity Hemolysin Proteins/toxicity Humans In Vitro Techniques Interleukin-1/metabolism Lipopolysaccharides/pharmacology Monocytes/drug effects,metabolism Monokines/metabolism Secretory Rate/drug effects
Chemicals
Hemolysin Proteins Interleukin-1 Lipopolysaccharides Monokines Adenosine Triphosphate
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bhakdi S
Institute of Medical Microbiology, University of Mainz, Federal Republic of Germany.
Muhly M
Korom S
Schmidt G
References (41)
41 references, click to expand
  1. Properties of strains of Escherichia coli isolated from a variety of sources.
    J Med Microbiol. 1975 Feb;8(1):107-11 PMID: 1092859
  2. Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone.
    J Immunol. 1988 Mar 15;140(6):1895-902 PMID: 3257992
  3. Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection.
    J Med Microbiol. 1980 Feb;13(1):57-68 PMID: 6102156
  4. Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.
    J Clin Microbiol. 1981 Jan;13(1):171-8 PMID: 7007421
  5. Characterization of pili associated with Escherichia coli O18ac.
    Infect Immun. 1980 Aug;29(2):685-91 PMID: 6111534
  6. Haemolysin contributes to virulence of extra-intestinal E. coli infections.
    Nature. 1981 Dec 17;294(5842):665-7 PMID: 7031483
  7. Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.
    Infect Immun. 1982 Jan;35(1):264-9 PMID: 6119294
  8. Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain.
    Infect Immun. 1982 Jan;35(1):32-7 PMID: 7033139
  9. Cytotoxic activity of partially purified Escherichia coli alpha haemolysin.
    J Med Microbiol. 1982 Feb;15(1):11-21 PMID: 6815328
  10. Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli.
    Infect Immun. 1983 Feb;39(2):546-51 PMID: 6339382
  11. Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes.
    J Exp Med. 1988 Feb 1;167(2):389-407 PMID: 3279153
  12. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.
    J Immunol. 1988 May 15;140(10):3473-81 PMID: 3258884
  13. Escherichia coli hemolysin permeabilizes small unilamellar vesicles loaded with calcein by a single-hit mechanism.
    FEBS Lett. 1988 May 9;232(1):217-20 PMID: 3284764
  14. Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets.
    J Exp Med. 1988 Aug 1;168(2):527-42 PMID: 3411289
  15. Interleukin-1 and its biologically related cytokines.
    Adv Immunol. 1989;44:153-205 PMID: 2466396
  16. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes.
    J Exp Med. 1989 Mar 1;169(3):737-54 PMID: 2538544
  17. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1.
    J Clin Invest. 1989 May;83(5):1614-22 PMID: 2785120
  18. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.
    J Clin Invest. 1989 Jul;84(1):220-7 PMID: 2500455
  19. Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro.
    Infect Immun. 1983 Jul;41(1):358-64 PMID: 6345395
  20. Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice.
    Infect Immun. 1983 Oct;42(1):57-63 PMID: 6352503
  21. Interleukin-1.
    Rev Infect Dis. 1984 Jan-Feb;6(1):51-95 PMID: 6369481
  22. Functional characterization of a cloned haemolysin determinant from E. coli of human origin, encoding information for the secretion of a 107K polypeptide.
    Mol Gen Genet. 1984;196(1):129-34 PMID: 6090863
  23. Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.
    J Immunol. 1985 Jan;134(1):343-9 PMID: 2578046
  24. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity.
    Microbiol Rev. 1984 Dec;48(4):326-43 PMID: 6394977
  25. Nucleotide sequence of an Escherichia coli chromosomal hemolysin.
    J Bacteriol. 1985 Jul;163(1):94-105 PMID: 3891743
  26. An update on human interleukin-1: from molecular biology to clinical relevance.
    J Clin Immunol. 1985 Sep;5(5):287-97 PMID: 3902871
  27. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.
    Infect Immun. 1986 Apr;52(1):63-9 PMID: 3514465
  28. Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin.
    J Immunol. 1986 Apr 15;136(8):2883-91 PMID: 2420874
  29. Immunocytochemical detection of interleukin 1 within stimulated human monocytes.
    J Exp Med. 1986 May 1;163(5):1267-80 PMID: 3517219
  30. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1363-75 PMID: 3011946
  31. Secretion of haemolysin by Escherichia coli.
    Curr Top Microbiol Immunol. 1986;125:159-81 PMID: 3017638
  32. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.
    J Biol Chem. 1987 Mar 5;262(7):2941-4 PMID: 2950091
  33. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells.
    Am J Pathol. 1987 Feb;126(2):350-7 PMID: 3030115
  34. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli.
    J Bacteriol. 1987 Apr;169(4):1509-15 PMID: 3549692
  35. Subcellular localization of human monocyte interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL 1 release.
    J Immunol. 1987 Jun 15;138(12):4249-55 PMID: 3495584
  36. Damage to mammalian cells by proteins that form transmembrane pores.
    Rev Physiol Biochem Pharmacol. 1987;107:147-223 PMID: 3303271
  37. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1.
    Infect Immun. 1987 Sep;55(9):1987-96 PMID: 3040588
  38. Development and use of a radioimmunoassay for human interleukin-1 beta.
    Lymphokine Res. 1987 Summer;6(3):229-44 PMID: 3498100
  39. Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes.
    Biochim Biophys Acta. 1987 Nov 27;905(1):109-17 PMID: 2445378
  40. Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli.
    Infect Immun. 1987 Dec;55(12):3233-6 PMID: 3316038
  41. Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates.
    Infect Immun. 1978 Apr;20(1):50-4 PMID: 352937
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1990-06-00
Pages
1746-53
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC296636
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com